Breaking
Friday, June 19, 2026

FDA News

🇺🇸 FDA Page 8

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.

Showing 85–96 of 391 articles

High impact NewsJun 4, 2026

Fierce Biotech Week 2026: Key Insights and Highlights

FDA · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 4, 2026

Drug Discovery USA 2026: What to Expect

FDA · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 4, 2026

ASCO Preview: Akeso's Ivonescimab Under Scrutiny

FDA · oncology · 6 min

Dr. Sarah Mitchell
High impact NewsJun 4, 2026

FDA Approves First Oral COVID-19 PEP Drug, Xocova

FDA · COVID-19 · 4 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

Explaining Unapproved Drugs to Payors: FDA Guidance Helps Pharma Avoid Pitfalls

FDA · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

AstraZeneca's Camizestrant: Navigating Divergent Regulatory Paths for Breast Cancer Treatment

FDA · breast cancer · 6 min

Dr. Sarah Mitchell
High impact NewsJun 3, 2026

FDA Blueprint Aims to Reduce Regulatory Risks for Animal Testing Alternatives

FDA · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

Why Optimistic Scientists Are Losing Heart: Insights from MIT

FDA · 6 min

Dr. Sarah Mitchell
High impact NewsJun 3, 2026

China’s Rise in Drug Development Looms Over U.S. Oncology Market

FDA · oncology · 5 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

FDA Approves Generic Eribulin Mesylate for Metastatic Breast Cancer

FDA · breast cancer · 5 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

Diversity in Medical Education: Bridging the Gap to a Representative Healthcare Workforce

FDA · 5 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

Impact of CDER Leadership Changes on Pharma Strategy

FDA · 5 min

Dr. Sarah Mitchell